 <h1>Zulresso Side Effects</h1><p class="drug-subtitle"><b>Generic Name:</b> <i>brexanolone</i></p><ul class="ddc-anchor-links"><li>Consumer</li>
<li>Professional</li>
<li>FAQ</li></ul><p class="ddc-notification"><b>Note:</b> This document contains side effect information about brexanolone. Some of the dosage forms listed on this page <em>may not</em> apply to the brand name Zulresso.</p><h2 class="ddc-anchor-offset" id="consumer">For the Consumer</h2><p><i>Applies to brexanolone: intravenous solution</i></p><h3>Warning</h3><p class="blackboxWarning-title">Intravenous route (Solution)</p><p>Warning: Excessive Sedation and Sudden Loss of ConsciousnessPatients are at risk of excessive sedation or sudden loss of consciousness during administration of brexanolone.Because of the risk of serious harm, patients must be monitored for excessive sedation and sudden loss of consciousness and have continuous pulse oximetry monitoring. Patients must be accompanied during interactions with their child(ren).Brexanolone is available only through a restricted program called the ZULRESSO REMS.</p><h3>Side effects requiring immediate medical attention</h3><p>Along with its needed effects, brexanolone (the active ingredient contained in Zulresso) may cause some unwanted effects. Although not all of these side effects may occur, if they do occur they may need medical attention.</p><p>
<i>Check with your doctor or nurse immediately</i> if any of the following side effects occur while taking brexanolone:</p><p>
<i>More common</i>
</p><ul>
<li>Dizziness or lightheadedness</li>
<li>drowsiness</li>
<li>fainting</li>
<li>feeling of constant movement of self or surroundings</li>
<li>relaxed and calm feeling</li>
<li>sensation of spinning</li>
<li>sleepiness or unusual drowsiness</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Fast, pounding, or irregular heartbeat or pulse</li>
<li>loss of consciousness</li>
</ul><p>
<i>Get emergency help immediately if any of the following symptoms of overdose occur while taking brexanolone:</i>
</p><p>
<i>Symptom of overdose</i>
</p><ul>
<li>Prolonged drowsiness</li>
</ul><h3>Side effects not requiring immediate medical attention</h3><p>Some side effects of brexanolone may occur that usually <b>do not need medical attention</b>. These side effects may go away during treatment as your body adjusts to the medicine. Also, your health care professional may be able to tell you about ways to prevent or reduce some of these side effects.</p><p>Check with your health care professional if any of the following side effects <b>continue or are bothersome</b> or if you have any questions about them:</p><p>
<i>More common</i>
</p><ul>
<li>Dry mouth</li>
</ul><p>
<i>Less common</i>
</p><ul>
<li>Belching</li>
<li>diarrhea</li>
<li>feeling of warmth</li>
<li>heartburn</li>
<li>indigestion</li>
<li>mouth or throat pain</li>
<li>redness of the face, neck, arms,  and occasionally, upper chest</li>
<li>stomach discomfort, upset, or pain</li>
</ul><p>
<!-- end intravenous solution --><div class="related-links"><svg aria-hidden="true" class="ddc-icon ddc-icon-info" focusable="false" height="22" viewbox="0 0 24 24" width="22" xmlns="http://www.w3.org/2000/svg"><path d="M14 2H6c-1.1 0-1.99.9-1.99 2L4 20c0 1.1.89 2 1.99 2H18c1.1 0 2-.9 2-2V8l-6-6zm2 16H8v-2h8v2zm0-4H8v-2h8v2zm-3-5V3.5L18.5 9H13z"></path></svg> <span>Managing side effects <span class="ddc-text-nowrap">(general information)</span></span></div>
<h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to brexanolone: intravenous solution</i></p><h3>General</h3><p>The most commonly reported side effects included sedation, somnolence, dizziness, presyncope, and vertigo.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Sedation (up to 21%), somnolence (up to 21%), dizziness (up to 13%), presyncope (up to 13%), vertigo (up to 13%)</p>
<p><b>Common</b> (1% to 10%): Loss of consciousness, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Dyspepsia was a dose-related side effect.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Dry mouth (up to 11%)</p>
<p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Tachycardia was a dose-related side effect.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Changes in blood pressure, flushing, hot flush, tachycardia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site events, infusion site pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, medication error (due to infusion pump malfunction)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Oropharyngeal pain<sup>[Ref]</sup></p><div class="referenceList"><h4 id="refs">References</h4><p id="ref_1">1. "Product Information. Zulresso (brexanolone)." Sage Therapeutics, Inc., Cambridge, MA. </p></div>
<h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2>
<ul>
<li>How is Zulresso administered for the treatment of Postpartum Depression?</li>
</ul>
<div class="more-resources" id="moreResources">
<h2>More about Zulresso (brexanolone)</h2>
<ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antidepressants</li>
<li>FDA Approval History</li>
</ul>
<h3>Consumer resources</h3>
<ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zulresso &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul>
<h3>Professional resources</h3>
<ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul>
<h3>Related treatment guides</h3>
<ul class="more-resources-list more-resources-list-conditions">
<li>Postpartum Depression</li>
</ul>
</div>
<h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p>
<p>Some side effects may not be reported. You may report them to the FDA.</p>
<p class="ddc-disclaimer-link">Medical Disclaimer</p>
<script>
function showRefs(refs) {
	if (!document.querySelectorAll) {
		return;
	}

	var referenceIds = refs ? refs.split(',') : [];
	var referenceTitle = referenceIds.length
		 ? "References relevant to chosen section <span class='ddc-text-size-small font-weight-normal'>(<a href='#refs' onclick='showRefs(\"\"); return false;'>Show all references</a>)</span>"
		 : "References";
	document.getElementById('refs').innerHTML = referenceTitle;

	// Show/hide reference items
	var referenceList = document.querySelectorAll('.referenceList p');
	referenceList.forEach(function(item) {
		var id = item.id.replace('ref_', '');
		if (!referenceIds.length || referenceIds.includes(id)) {
			item.style.display = 'block';
		}
		else {
			item.style.display = 'none';
		}
	});
}
</script>
</p><h2 class="ddc-anchor-offset" id="professional">For Healthcare Professionals</h2><p><i>Applies to brexanolone: intravenous solution</i></p><h3>General</h3><p>The most commonly reported side effects included sedation, somnolence, dizziness, presyncope, and vertigo.<sup>[Ref]</sup></p><h3>Nervous system</h3><p><b>Very common</b> (10% or more): Sedation (up to 21%), somnolence (up to 21%), dizziness (up to 13%), presyncope (up to 13%), vertigo (up to 13%)</p><p><b>Common</b> (1% to 10%): Loss of consciousness, syncope<sup>[Ref]</sup></p><h3>Gastrointestinal</h3><p>Dyspepsia was a dose-related side effect.<sup>[Ref]</sup></p><p><b>Very common</b> (10% or more): Dry mouth (up to 11%)</p><p><b>Common</b> (1% to 10%): Diarrhea, dyspepsia<sup>[Ref]</sup></p><h3>Cardiovascular</h3><p>Tachycardia was a dose-related side effect.<sup>[Ref]</sup></p><p><b>Common</b> (1% to 10%): Changes in blood pressure, flushing, hot flush, tachycardia<sup>[Ref]</sup></p><h3>Local</h3><p><b>Common</b> (1% to 10%): Infusion site events, infusion site pain<sup>[Ref]</sup></p><h3>Other</h3><p><b>Common</b> (1% to 10%): Fatigue, medication error (due to infusion pump malfunction)<sup>[Ref]</sup></p><h3>Respiratory</h3><p><b>Common</b> (1% to 10%): Oropharyngeal pain<sup>[Ref]</sup></p><p id="ref_1">1. "Product Information. Zulresso (brexanolone)." Sage Therapeutics, Inc., Cambridge, MA. </p><h2 class="ddc-anchor-offset" id="faq">Frequently asked questions</h2><ul>
<li>How is Zulresso administered for the treatment of Postpartum Depression?</li>
</ul><h2>More about Zulresso (brexanolone)</h2><ul class="more-resources-list more-resources-list-general">
<li>During Pregnancy or 
Breastfeeding</li>
<li>Dosage Information</li>
<li>Drug Interactions</li>
<li>Pricing &amp; Coupons</li>
<li>En Español</li>
<li>Drug class: miscellaneous antidepressants</li>
<li>FDA Approval History</li>
</ul><h3>Consumer resources</h3><ul class="more-resources-list more-resources-list-consumer">
<li>Patient Information</li>
<li>Zulresso &lt;span&gt;(Advanced Reading)&lt;/span&gt;</li>
</ul><h3>Professional resources</h3><ul class="more-resources-list more-resources-list-professional">
<li>Prescribing Information</li>
<li data-more-config-id="list-data-resources-professional">... +1 more</li>
</ul><h3>Related treatment guides</h3><ul class="more-resources-list more-resources-list-conditions">
<li>Postpartum Depression</li>
</ul><h2>Further information</h2><p class="ddc-disclaimer">Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.</p><p>Some side effects may not be reported. You may report them to the FDA.</p><p class="ddc-disclaimer-link">Medical Disclaimer</p>